These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 177787)

  • 1. Mammary gland as a morphological end point in carcinogenesis studies.
    Medina D
    J Toxicol Environ Health; 1976 Mar; 1(4):551-60. PubMed ID: 177787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preneoplastic lesions in murine mammary cancer.
    Medina D
    Cancer Res; 1976 Jul; 36(7 PT 2):2589-95. PubMed ID: 179706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in progression of BALB/cfRIII and BALB/cfC3H mammary hyperplastic alveolar nodules transplanted into the gland-free fat pads of BALB/c mice.
    Basolo F; Fontanini G; Squartini F
    Cancer Res; 1988 Jun; 48(11):3197-202. PubMed ID: 2835155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenic capacity of preneoplastic lesions of the murine mammary gland as a marker of neoplastic transformation.
    Gimbrone MA; Gullino PM
    Cancer Res; 1976 Jul; 36(7 PT 2):2611-20. PubMed ID: 1277168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro transformation of mouse mammary epithelial cells grown serum-free inside collagen gels.
    Guzman RC; Osborn RC; Bartley JC; Imagawa W; Asch BB; Nandi S
    Cancer Res; 1987 Jan; 47(1):275-80. PubMed ID: 3098407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential expression of preneoplastic and neoplastic characteristics of mouse mammary epithelial cells transformed in organ culture.
    Iyer AP; Banerjee MR
    J Natl Cancer Inst; 1981 May; 66(5):893-905. PubMed ID: 6785507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of tumorigenicity with morphological progression in a BALB/c preneoplastic outgrowth line.
    Medina D; Kittrell FS
    J Natl Cancer Inst; 1987 Sep; 79(3):569-76. PubMed ID: 3041094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urethan-induced mammary tumorigenesis in a murine mammary tumor virus (MuMTV)-positive mouse strain: evidence for a keratinized nodule as an MuMTV-negative precursor lesion for squamous cell tumors.
    Imai S; Tsubura Y; Hilgers J
    J Natl Cancer Inst; 1984 Oct; 73(4):935-41. PubMed ID: 6090751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nononcogenic hormone-independent alveoli produced by carcinogens in cultured mouse mammary glands.
    Schaefer FV; Tonelli QJ; Dickens MS; Custer RP; Sorof S
    Cancer Res; 1983 Jul; 43(7):3310-5. PubMed ID: 6406057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restriction endonuclease studies of hyperplastic outgrowth lines from BALB/cfC3H mouse hyperplastic mammary nodules.
    Cardiff RD; Fanning TG; Morris DW; Ashley RL; Faulkin LJ
    Cancer Res; 1981 Aug; 41(8):3024-9. PubMed ID: 6265073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperplastic lesions of mouse mammary glands after treatment with 3-methylcholanthrene.
    Faulkin LJ
    J Natl Cancer Inst; 1966 Feb; 36(2):289-97. PubMed ID: 4286277
    [No Abstract]   [Full Text] [Related]  

  • 12. Lobuloalveolar differentiation and tumorigenesis: two separate activities of mouse mammary tumor virus.
    Squartini F; Basolo F; Bistocchi M
    Cancer Res; 1983 Dec; 43(12 Pt 1):5879-82. PubMed ID: 6315219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of mammary tumor virus proteins in preneoplastic outgrowth lines and mammary tumors of BALB/cV mice.
    Slagle BL; Lanford RE; Medina D; Butel JS
    Cancer Res; 1984 May; 44(5):2155-62. PubMed ID: 6324998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
    Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological and functional properties of TM preneoplastic mammary outgrowths.
    Medina D; Kittrell FS; Liu YJ; Schwartz M
    Cancer Res; 1993 Feb; 53(3):663-7. PubMed ID: 7678778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of the BALB/cNIV mouse strain.
    Young LJ; DeOme KB; Blair PB; Pitelka DR; Cardiff RD
    Cancer Res; 1984 Oct; 44(10):4333-6. PubMed ID: 6088036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reevaluation of the effect of mouse mammary tumor virus infection on the BALB/c mouse hyperplastic outgrowth.
    Ashley RL; Cardiff RD; Fanning TG
    J Natl Cancer Inst; 1980 Nov; 65(5):977-86. PubMed ID: 6253710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroma is not a major target in DMBA-mediated tumorigenesis of mouse mammary preneoplasia.
    Medina D; Kittrell F
    J Cell Sci; 2005 Jan; 118(Pt 1):123-7. PubMed ID: 15585572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal induction of mammary tumor viruses and its implications for carcinogenesis.
    McGrath CM; Jones RF
    Cancer Res; 1978 Nov; 38(11 Pt 2):4112-25. PubMed ID: 212187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities.
    Tekmal RR; Ramachandra N; Gubba S; Durgam VR; Mantione J; Toda K; Shizuta Y; Dillehay DL
    Cancer Res; 1996 Jul; 56(14):3180-5. PubMed ID: 8764102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.